Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Sahin H Bahar"'
Autor:
Gautreau Alexis, Carrera Pilar, Sahin H Bahar, Qurashi Abrar, Schenck Annette, Giangrande Angela
Publikováno v:
Neural Development, Vol 2, Iss 1, p 18 (2007)
Abstract Background The WAVE/SCAR complex, consisting of CYFIP (PIR121 or Sra1), Kette (Nap1), Abi, SCAR (WAVE) and HSPC300, is known to regulate the actin nucleating Arp2/3 complex in a Rac1-dependent manner. While in vitro and in vivo studies have
Externí odkaz:
https://doaj.org/article/adba8fcfbda2415c844ed3c49961aeca
Autor:
Galy, Anne, Schenck, Annette, Sahin, H. Bahar, Qurashi, Abrar, Sahel, José-Alain, Diebold, Céline, Giangrande, Angela
Publikováno v:
In Developmental Biology 1 November 2011 359(1):37-46
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Qurashi, Abrar1,2 qurashi.abrar@gmail.com, Sahin, H. Bahar1 bahars@titus.u-strasbg.fr, Carrera, Pilar1,3 pcarrera@uni-bonn.de, Gautreau, Alexis4 alexis.gautreau@curie.fr, Schenck, Annette1,5 a.schenck@antrg.umcn.nl, Giangrande, Angela1 angela@igbmc.u-strasbg.fr
Publikováno v:
Neural Development. 2007, Vol. 2, p18-30. 13p.
Autor:
Abekhoukh, Sabiha, Sahin, H. Bahar, Grossi, Mauro, Zongaro, Samantha, Maurin, Thomas, Madrigal, Irene, Kazue-Sugioka, Daniele, Raas-Rothschild, Annick, Doulazmi, Mohamed, Carrera, Pilar, Stachon, Andrea, Scherer, Steven, Drula Do Nascimento, Maria Rita, Trembleau, Alain, Arroyo, Ignacio, Szatmari, Peter, Smith, Isabel M., Milà, Montserrat, Smith, Adam C., Giangrande, Angela, Caillé, Isabelle, Bardoni, Barbara
Publikováno v:
Disease Models & Mechanisms
Disease Models & Mechanisms, Cambridge Company of Biologists, 2017, 10 (4), pp.463-474. ⟨10.1242/dmm.025809⟩
Disease Models & Mechanisms, 2017, 10 (4), pp.463-474. ⟨10.1242/dmm.025809⟩
Disease Models & Mechanisms, Vol 10, Iss 4, Pp 463-474 (2017)
Disease Models & Mechanisms, Cambridge Company of Biologists, 2017, 10 (4), pp.463-474. ⟨10.1242/dmm.025809⟩
Disease Models & Mechanisms, 2017, 10 (4), pp.463-474. ⟨10.1242/dmm.025809⟩
Disease Models & Mechanisms, Vol 10, Iss 4, Pp 463-474 (2017)
Cytoplasmic FMRP interacting protein 1 (CYFIP1) is a candidate gene for intellectual disability (ID), autism, schizophrenia and epilepsy. It is a member of a family of proteins that is highly conserved during evolution, sharing high homology with its
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::97d9183c2ec5ac885a15f5df97bac39f
https://hal.sorbonne-universite.fr/hal-01519686/document
https://hal.sorbonne-universite.fr/hal-01519686/document
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Abekhoukh S; Université Côte d'Azur, Nice, France.; CNRS UMR 7275, Institute of Molecular and Cellular Pharmacology, 06560 Valbonne, France.; CNRS Associated International Laboratory (LIA) 'Neogenex', 06560 Valbonne, France., Sahin HB; Institut de Génétique et de Biologie Moléculaire et Cellulaire, 67400 Illkirch, France.; CNRS, UMR7104, 67400 Illkirch, France.; Institut National de la Santé et de la Recherche Médicale, U964, 67400 Illkirch, France.; Université de Strasbourg, 67404 Illkirch, France., Grossi M; Université Côte d'Azur, Nice, France.; CNRS UMR 7275, Institute of Molecular and Cellular Pharmacology, 06560 Valbonne, France.; CNRS Associated International Laboratory (LIA) 'Neogenex', 06560 Valbonne, France., Zongaro S; Université Côte d'Azur, Nice, France.; CNRS UMR 7275, Institute of Molecular and Cellular Pharmacology, 06560 Valbonne, France.; CNRS Associated International Laboratory (LIA) 'Neogenex', 06560 Valbonne, France., Maurin T; Université Côte d'Azur, Nice, France.; CNRS UMR 7275, Institute of Molecular and Cellular Pharmacology, 06560 Valbonne, France.; CNRS Associated International Laboratory (LIA) 'Neogenex', 06560 Valbonne, France., Madrigal I; Biochemistry and Molecular Genetics Department, Hospital Clinic, 08036 Barcelona, Spain.; Center for Biomedical Research on Rare Diseases (CIBERER), Barcelona, Spain.; IDIBAPS, Barcelona, Spain., Kazue-Sugioka D; Université Côte d'Azur, Nice, France.; CNRS UMR 7275, Institute of Molecular and Cellular Pharmacology, 06560 Valbonne, France.; CNRS Associated International Laboratory (LIA) 'Neogenex', 06560 Valbonne, France.; Instituto de Pesquisa Pelé Pequeno Principe, Curitiba 80250-060, Brazil., Raas-Rothschild A; Institute of Rare Diseases, Institute of Medical Genetics, The Chaim Sheba Medical Center, Tel Hashomer 52621, Israel., Doulazmi M; Sorbonne Universités, Université Pierre et Marie Curie, Univ Paris 06, CNRS UMR8256, IBPS, Neuroscience Paris Seine, France., Carrera P; Institut de Génétique et de Biologie Moléculaire et Cellulaire, 67400 Illkirch, France.; CNRS, UMR7104, 67400 Illkirch, France.; Institut National de la Santé et de la Recherche Médicale, U964, 67400 Illkirch, France.; Université de Strasbourg, 67404 Illkirch, France., Stachon A; Instituto de Pesquisa Pelé Pequeno Principe, Curitiba 80250-060, Brazil., Scherer S; Hospital for Sick Children, Toronto, Ontario, Canada, M5G 1X8., Drula Do Nascimento MR; Instituto de Pesquisa Pelé Pequeno Principe, Curitiba 80250-060, Brazil., Trembleau A; Sorbonne Universités, Université Pierre et Marie Curie, Univ Paris 06, CNRS UMR8256, IBPS, Neuroscience Paris Seine, France., Arroyo I; Center for Biomedical Research on Rare Diseases (CIBERER), Barcelona, Spain., Szatmari P; Centre for Addiction and Mental Health, Hospital for Sick Children, Department of Psychiatry, University of Toronto, Canada, M5G 1X8., Smith IM; Departments of Pediatrics and Psychology & Neuroscience, Dalhousie University and IWK Health Centre, Halifax, Canada, B3K 6R8., Milà M; Biochemistry and Molecular Genetics Department, Hospital Clinic, 08036 Barcelona, Spain.; Center for Biomedical Research on Rare Diseases (CIBERER), Barcelona, Spain.; IDIBAPS, Barcelona, Spain., Smith AC; Instituto de Pesquisa Pelé Pequeno Principe, Curitiba 80250-060, Brazil.; Department of Laboratory Medicine and Pathobiology, Faculty of Medicine, University of Toronto and Program in Laboratory Medicine, University Health Network, Toronto, Canada., Giangrande A; Institut de Génétique et de Biologie Moléculaire et Cellulaire, 67400 Illkirch, France.; CNRS, UMR7104, 67400 Illkirch, France.; Institut National de la Santé et de la Recherche Médicale, U964, 67400 Illkirch, France.; Université de Strasbourg, 67404 Illkirch, France., Caillé I; Sorbonne Universités, Université Pierre et Marie Curie, Univ Paris 06, CNRS UMR8256, IBPS, Neuroscience Paris Seine, France.; Sorbonne Paris Cité, Université Paris Diderot-Paris 7, 75013 Paris, France., Bardoni B; Université Côte d'Azur, Nice, France bardoni@ipmc.cnrs.fr.; CNRS UMR 7275, Institute of Molecular and Cellular Pharmacology, 06560 Valbonne, France.; CNRS Associated International Laboratory (LIA) 'Neogenex', 06560 Valbonne, France.
Publikováno v:
Disease models & mechanisms [Dis Model Mech] 2017 Apr 01; Vol. 10 (4), pp. 463-474. Date of Electronic Publication: 2017 Feb 09.